SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-011843
Filing Date
2021-02-03
Accepted
2021-02-03 21:50:14
Documents
2
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm215262-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm215262-1_3seq1.xml 3 2537
2 EXHIBIT 24.1 tm215262d1_ex24-1.htm EX-24.1 9981
  Complete submission text file 0001104659-21-011843.txt   13944
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLEY OAKS ROAD, SUITE 108 WALTHAM MA 02452
Business Address
Obermayr Franz (Reporting) CIK: 0001843571 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 21588626